ロード中...
Immune checkpoint inhibitors therapy in older patients (≥ 70 years) with metastatic melanoma: a multicentre study
INTRODUCTION: The use of immunotherapy in older patients remains challenging due to very few data on the efficacy and safety of treatment in this group. AIM: To analyse the efficacy and safety of immunotherapy with checkpoint inhibitors in older patients (≥ 70 years) with metastatic melanoma. MATERI...
保存先:
| 出版年: | Postepy Dermatol Alergol |
|---|---|
| 主要な著者: | , , , , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Termedia Publishing House
2019
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6906963/ https://ncbi.nlm.nih.gov/pubmed/31839773 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5114/ada.2018.79940 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|